Incretin Pharmacotherapy in Practice: What the Drugs Do, What the Trials Prove, and What the Weight Loss Is Made Of
A clinical account of GLP-1 and dual-agonist therapy, SGLT2 inhibitors and metformin — the outcomes each class has actually demonstrated, how to protect lean mass, and how to frame duration before the first prescription.
Tuesday, September 29, 2026 0 views
About This Tutorial
A clinical account of GLP-1 and dual-agonist therapy, SGLT2 inhibitors and metformin — the outcomes each class has actually demonstrated, how to protect lean mass, and how to frame duration before the first prescription.
Tutorials Are a Paid Feature
Interactive tutorials with quizzes and score tracking are available to Practitioner members and above. Sign in to try one tutorial for free!
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe:
